CSIMarket
 


Acura Pharmaceuticals inc  (ACUR)
Other Ticker:  
 
 

ACUR's Income from Cont. Operations Growth by Quarter and Year

Acura Pharmaceuticals Inc's Income from Cont. Operations results by quarter and year




ACUR Income from Cont. Operations (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December 0.03 -0.24 0.16 0.01
III Quarter September -0.26 -0.68 0.20 -1.10
II Quarter June -0.39 0.31 -3.34 -1.26
I Quarter March -0.26 -0.60 -0.79 -1.49
FY   -0.88 -1.21 -3.77 -3.84



ACUR Income from Cont. Operations fourth quarter 2021 Y/Y Growth Comment
Acura Pharmaceuticals inc in the fourth quarter 2021 achieved Income from Cont. Operations of $ 0.03 millions compare to loss from continued operations recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2021, Acura Pharmaceuticals Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Acura Pharmaceuticals Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2021.




ACUR Income from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - 1500 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Acura Pharmaceuticals Inc's fourth quarter 2021 Income from Cont. Operations $ 0.03 millions ACUR's Income Statement
Acura Pharmaceuticals Inc's fourth quarter 2020 Income from Cont. Operations $ -0.24 millions Quarterly ACUR's Income Statement
New: More ACUR's historic Income from Cont. Operations Growth >>


ACUR Income from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - -20 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Acura Pharmaceuticals Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACUR's IV. Quarter Q/Q Income from Cont. Operations Comment
This reversal of fortune IV. Quarter 2021where Acura Pharmaceuticals inc delivered Income from Cont. Operations of $ 0.03 millions could be considered as a beginning of better performance.Acura Pharmaceuticals inc announced in the IV. Quarter 2021 Income from Cont. Operations of $ 0.03 millions compare to loss from continued operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Acura Pharmaceuticals inc achieved highest sequential Income from Cont. Operations growth. While Acura Pharmaceuticals Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACUR's IV. Quarter Q/Q Income from Cont. Operations Comment
This turnaround IV. Quarter 2021where Acura Pharmaceuticals inc published Income from Cont. Operations of $ 0.03 millions should is inception of better performance.Acura Pharmaceuticals inc announced in the IV. Quarter 2021 Income from Cont. Operations of $ 0.03 millions compare to loss from continued operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Acura Pharmaceuticals inc achieved highest sequential Income from Cont. Operations growth. While Acura Pharmaceuticals Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Acura Pharmaceuticals Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending $ -0.88 $ -1.15 $ -1.57 $ -0.87 $ -1.21
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Acura Pharmaceuticals inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Acura Pharmaceuticals inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ACUR's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ACUR's Competitors
Income from Cont. Operations Growth for Acura Pharmaceuticals Inc's Suppliers
Income from Cont. Operations Growth for ACUR's Customers

You may also want to know
ACUR's Annual Growth Rates ACUR's Profitability Ratios ACUR's Asset Turnover Ratio ACUR's Dividend Growth
ACUR's Roe ACUR's Valuation Ratios ACUR's Financial Strength Ratios ACUR's Dividend Payout Ratio
ACUR's Roa ACUR's Inventory Turnover Ratio ACUR's Growth Rates ACUR's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2021
Medpace Holdings Inc -1.64%$ -1.636 millions
Davita Inc -1.80%$ -1.800 millions
Charles River Laboratories International inc -3.03%$ -3.026 millions
3m Company-3.60%$ -3.597 millions
Idexx Laboratories Inc-6.97%$ -6.966 millions
Abbott Laboratories-7.83%$ -7.831 millions
Dr Reddy s Laboratories Limited-8.88%$ -8.880 millions
Horizon Therapeutics Public Limited Company-9.12%$ -9.118 millions
Surgery Partners Inc -10.44%$ -10.438 millions
Lemaitre Vascular Inc -12.20%$ -12.200 millions
Vanda Pharmaceuticals Inc -13.58%$ -13.578 millions
Fresenius Medical Care Ag-15.10%$ -15.100 millions
Integrated Biopharma Inc-15.77%$ -15.768 millions
Owens and Minor inc-17.28%$ -17.276 millions
Syneos Health Inc -17.33%$ -17.333 millions
Eli Lilly And Company-18.46%$ -18.457 millions
Catalyst Pharmaceuticals Inc -18.61%$ -18.607 millions
Viemed Healthcare Inc -19.40%$ -19.404 millions
Xoma Corporation-19.42%$ -19.421 millions
Halozyme Therapeutics Inc -20.10%$ -20.100 millions
Gsk Plc-20.23%$ -20.225 millions
Ufp Technologies Inc -22.84%$ -22.843 millions
Tenet Healthcare Corp-23.08%$ -23.077 millions
Hologic Inc-23.72%$ -23.716 millions
Universal Health Services Inc -23.99%$ -23.989 millions
Amedisys Inc -25.38%$ -25.384 millions
Abiomed Inc -26.05%$ -26.049 millions
Electromed Inc -30.37%$ -30.366 millions
Chemed Corporation-30.63%$ -30.633 millions
Quest Diagnostics Inc-32.18%$ -32.184 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com